Bio Total Assets vs Accumulated Depreciation Analysis

BPTH Stock  USD 0.68  0.03  4.23%   
Bio Path financial indicator trend analysis is way more than just evaluating Bio Path Holdings prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bio Path Holdings is a good investment. Please check the relationship between Bio Path Total Assets and its Accumulated Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Total Assets vs Accumulated Depreciation

Total Assets vs Accumulated Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bio Path Holdings Total Assets account and Accumulated Depreciation. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Bio Path's Total Assets and Accumulated Depreciation is -0.45. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Accumulated Depreciation in the same time period over historical financial statements of Bio Path Holdings, assuming nothing else is changed. The correlation between historical values of Bio Path's Total Assets and Accumulated Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Bio Path Holdings are associated (or correlated) with its Accumulated Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accumulated Depreciation has no effect on the direction of Total Assets i.e., Bio Path's Total Assets and Accumulated Depreciation go up and down completely randomly.

Correlation Coefficient

-0.45
Relationship DirectionNegative 
Relationship StrengthVery Weak

Total Assets

Total assets refers to the total amount of Bio Path assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bio Path Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Accumulated Depreciation

Accumulated depreciation is the total amount of depreciation for Bio Path Holdings fixed asset that has been charged to Bio Path expense since that asset was acquired and made available for Bio Path use. The accumulated depreciation account is Bio Path Holdings asset account with a credit balance. It is also known as a contra asset account and appears on the balance sheet as a reduction from the gross amount of fixed assets reported by Bio Path Holdings.
Most indicators from Bio Path's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bio Path Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
The Bio Path's current Sales General And Administrative To Revenue is estimated to increase to 179.88, while Selling General Administrative is projected to decrease to under 2.4 M.
 2021 2022 2023 2024 (projected)
Net Interest Income3K33K52K32.5K
Interest Income3K33K52K31.0K

Bio Path fundamental ratios Correlations

0.080.280.20.990.52-0.28-0.99-0.29-0.060.99-0.09-0.420.99-0.11-0.07-0.06-0.150.40.450.120.361.00.2-0.56-0.15
0.08-0.42-0.560.130.12-0.25-0.110.68-0.280.110.78-0.180.110.920.24-0.010.32-0.6-0.61-0.36-0.690.02-0.820.010.54
0.28-0.420.870.170.39-0.52-0.23-0.790.240.23-0.35-0.010.23-0.390.30.41-0.070.530.790.80.710.30.59-0.67-0.32
0.2-0.560.870.10.39-0.46-0.13-0.940.670.13-0.6-0.120.13-0.50.250.33-0.240.710.910.760.830.240.72-0.68-0.61
0.990.130.170.10.46-0.24-0.99-0.21-0.10.99-0.06-0.420.99-0.07-0.11-0.18-0.110.340.38-0.010.280.990.15-0.49-0.13
0.520.120.390.390.46-0.26-0.48-0.380.230.49-0.15-0.380.49-0.010.080.4-0.490.290.440.480.450.520.09-0.64-0.48
-0.28-0.25-0.52-0.46-0.24-0.260.230.44-0.28-0.23-0.280.04-0.23-0.26-0.6-0.16-0.05-0.24-0.46-0.34-0.33-0.26-0.150.690.08
-0.99-0.11-0.23-0.13-0.99-0.480.230.230.11-1.00.090.45-1.00.070.10.080.13-0.3-0.39-0.08-0.29-0.99-0.130.510.11
-0.290.68-0.79-0.94-0.21-0.380.440.23-0.6-0.230.670.06-0.230.66-0.17-0.160.37-0.8-0.98-0.63-0.93-0.34-0.850.670.74
-0.06-0.280.240.67-0.10.23-0.280.11-0.6-0.11-0.52-0.25-0.11-0.190.240.12-0.30.510.550.340.51-0.020.38-0.41-0.63
0.990.110.230.130.990.49-0.23-1.0-0.23-0.11-0.1-0.461.0-0.08-0.11-0.08-0.130.30.40.080.290.990.13-0.51-0.12
-0.090.78-0.35-0.6-0.06-0.15-0.280.090.67-0.52-0.10.1-0.10.790.220.030.35-0.55-0.64-0.29-0.6-0.17-0.670.240.71
-0.42-0.18-0.01-0.12-0.42-0.380.040.450.06-0.25-0.460.1-0.46-0.20.410.030.10.07-0.14-0.07-0.04-0.430.190.160.19
0.990.110.230.130.990.49-0.23-1.0-0.23-0.111.0-0.1-0.46-0.08-0.11-0.08-0.130.30.40.080.290.990.13-0.51-0.12
-0.110.92-0.39-0.5-0.07-0.01-0.260.070.66-0.19-0.080.79-0.2-0.080.360.070.34-0.7-0.64-0.28-0.66-0.17-0.890.060.59
-0.070.240.30.25-0.110.08-0.60.1-0.170.24-0.110.220.41-0.110.360.30.090.020.120.250.13-0.09-0.08-0.560.11
-0.06-0.010.410.33-0.180.4-0.160.08-0.160.12-0.080.030.03-0.080.070.3-0.240.050.120.840.23-0.06-0.02-0.230.16
-0.150.32-0.07-0.24-0.11-0.49-0.050.130.37-0.3-0.130.350.1-0.130.340.09-0.24-0.32-0.37-0.28-0.46-0.17-0.320.20.49
0.4-0.60.530.710.340.29-0.24-0.3-0.80.510.3-0.550.070.3-0.70.020.05-0.320.810.450.820.440.88-0.49-0.55
0.45-0.610.790.910.380.44-0.46-0.39-0.980.550.4-0.64-0.140.4-0.640.120.12-0.370.810.60.930.50.82-0.71-0.71
0.12-0.360.80.76-0.010.48-0.34-0.08-0.630.340.08-0.29-0.070.08-0.280.250.84-0.280.450.60.630.150.42-0.5-0.19
0.36-0.690.710.830.280.45-0.33-0.29-0.930.510.29-0.6-0.040.29-0.660.130.23-0.460.820.930.630.40.79-0.59-0.69
1.00.020.30.240.990.52-0.26-0.99-0.34-0.020.99-0.17-0.430.99-0.17-0.09-0.06-0.170.440.50.150.40.25-0.57-0.2
0.2-0.820.590.720.150.09-0.15-0.13-0.850.380.13-0.670.190.13-0.89-0.08-0.02-0.320.880.820.420.790.25-0.37-0.61
-0.560.01-0.67-0.68-0.49-0.640.690.510.67-0.41-0.510.240.16-0.510.06-0.56-0.230.2-0.49-0.71-0.5-0.59-0.57-0.370.42
-0.150.54-0.32-0.61-0.13-0.480.080.110.74-0.63-0.120.710.19-0.120.590.110.160.49-0.55-0.71-0.19-0.69-0.2-0.610.42
Click cells to compare fundamentals

Bio Path Account Relationship Matchups

Bio Path fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets22.7M16.5M26.6M16.0M3.2M3.1M
Other Current Liab673K881K688K801K1.2M1.3M
Total Current Liabilities1.2M1.2M958K1.7M1.9M2.0M
Total Stockholder Equity21.1M15.1M25.5M14.2M441K419.0K
Property Plant And Equipment Net670K519K428K356K178K344.7K
Net Debt(20.0M)(13.4M)(23.5M)(10.2M)(939K)(986.0K)
Retained Earnings(56.3M)(67.2M)(77.7M)(91.5M)(107.6M)(102.2M)
Accounts Payable486K100K106K667K457K479.9K
Cash20.4M13.8M23.8M10.4M1.1M999.4K
Non Current Assets Total670K519K428K356K178K169.1K
Non Currrent Assets Other(13.4M)288K225K158K76K79.8K
Cash And Short Term Investments20.4M13.8M23.8M10.4M1.1M999.4K
Common Stock Shares Outstanding132.9K192.4K336.3K363.8K478K292.6K
Liabilities And Stockholders Equity22.7M16.5M26.6M16.0M3.2M3.1M
Non Current Liabilities Total330K236K153K113K873K916.7K
Other Current Assets788K2.2M2.4M5.2M2.0M2.1M
Other Stockholder Equity77.4M82.3M103.1M105.7M108.0M113.4M
Total Liab1.6M1.4M1.1M1.8M2.8M2.9M
Property Plant And Equipment Gross670K519K1.3M1.3M1.2M1.3M
Total Current Assets22.0M16.0M26.1M15.6M3.0M2.9M
Common Stock1K4K5K7K8K950.0
Common Stock Total Equity11K1K4K5K4.5K4.3K
Net Tangible Assets1.2M21.1M15.1M25.5M29.3M30.7M
Retained Earnings Total Equity(39.2M)(47.7M)(56.3M)(67.2M)(60.5M)(57.5M)
Capital Surpluse47.2M49.0M77.4M82.3M94.6M99.4M
Property Plant Equipment406K303K231K428K492.2K282.1K
Accumulated Depreciation(330K)(592K)(726K)(798K)(718.2K)(682.3K)
Net Invested Capital21.1M15.1M25.5M14.2M441K419.0K
Net Working Capital20.7M14.8M25.2M13.9M1.1M1.1M

Currently Active Assets on Macroaxis

When determining whether Bio Path Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Path's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Path Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Path Holdings Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Path. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Path listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.34)
Return On Assets
(1.40)
Return On Equity
(3.66)
The market value of Bio Path Holdings is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Path's value that differs from its market value or its book value, called intrinsic value, which is Bio Path's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Path's market value can be influenced by many factors that don't directly affect Bio Path's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Path's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Path is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Path's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.